Literature DB >> 17204652

Differential antigen processing by dendritic cell subsets in vivo.

Diana Dudziak1, Alice O Kamphorst, Gordon F Heidkamp, Veit R Buchholz, Christine Trumpfheller, Sayuri Yamazaki, Cheolho Cheong, Kang Liu, Han-Woong Lee, Chae Gyu Park, Ralph M Steinman, Michel C Nussenzweig.   

Abstract

Dendritic cells (DCs) process and present self and foreign antigens to induce tolerance or immunity. In vitro models suggest that induction of immunity is controlled by regulating the presentation of antigen, but little is known about how DCs control antigen presentation in vivo. To examine antigen processing and presentation in vivo, we specifically targeted antigens to two major subsets of DCs by using chimeric monoclonal antibodies. Unlike CD8+ DCs that express the cell surface protein CD205, CD8- DCs, which are positive for the 33D1 antigen, are specialized for presentation on major histocompatibility complex (MHC) class II. This difference in antigen processing is intrinsic to the DC subsets and is associated with increased expression of proteins involved in MHC processing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17204652     DOI: 10.1126/science.1136080

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  568 in total

1.  Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α- dendritic cell subset.

Authors:  Shinji Kasahara; Edward A Clark
Journal:  J Leukoc Biol       Date:  2011-12-06       Impact factor: 4.962

Review 2.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

Authors:  Eynav Klechevsky; Anne-Laure Flamar; Yanying Cao; Jean-Philippe Blanck; Maochang Liu; Amy O'Bar; Olivier Agouna-Deciat; Peter Klucar; Luann Thompson-Snipes; Sandra Zurawski; Yoram Reiter; A Karolina Palucka; Gerard Zurawski; Jacques Banchereau
Journal:  Blood       Date:  2010-06-07       Impact factor: 22.113

Review 4.  Targeting human dendritic cell subsets for improved vaccines.

Authors:  Hideki Ueno; Eynav Klechevsky; Nathalie Schmitt; Ling Ni; Anne-Laure Flamar; Sandra Zurawski; Gerard Zurawski; Karolina Palucka; Jacques Banchereau; Sangkon Oh
Journal:  Semin Immunol       Date:  2011-01-28       Impact factor: 11.130

5.  The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming.

Authors:  Jacques Banchereau; LuAnn Thompson-Snipes; Sandra Zurawski; Jean-Philippe Blanck; Yanying Cao; Sandra Clayton; Jean-Pierre Gorvel; Gerard Zurawski; Eynav Klechevsky
Journal:  Blood       Date:  2012-04-25       Impact factor: 22.113

6.  Opposing Roles of Dendritic Cell Subsets in Experimental GN.

Authors:  Sebastian Brähler; Bernd H Zinselmeyer; Saravanan Raju; Maximilian Nitschke; Hani Suleiman; Brian T Saunders; Michael W Johnson; Alexander M C Böhner; Susanne F Viehmann; Derek J Theisen; Nicole M Kretzer; Carlos G Briseño; Konstantin Zaitsev; Olga Ornatsky; Qing Chang; Javier A Carrero; Jeffrey B Kopp; Maxim N Artyomov; Christian Kurts; Kenneth M Murphy; Jeffrey H Miner; Andrey S Shaw
Journal:  J Am Soc Nephrol       Date:  2017-12-07       Impact factor: 10.121

7.  Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells.

Authors:  Michael Y Gerner; Matthew F Mescher
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

Authors:  Eynav Klechevsky; Maochang Liu; Rimpei Morita; Romain Banchereau; Luann Thompson-Snipes; A Karolina Palucka; Hideki Ueno; Jacques Banchereau
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

9.  Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

Authors:  YuFeng Peng; Yvette Latchman; Keith B Elkon
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Authors:  Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Mol Pharm       Date:  2012-11-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.